BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11058695)

  • 1. Soluble receptors for tumor necrosis factor-alpha (TNF-R p55 and TNF-R p75) in familial combined hyperlipidemia.
    van Greevenbroek MM; van der Kallen CJ; Geurts JM; Janssen RG; Buurman WA; de Bruin TW
    Atherosclerosis; 2000 Nov; 153(1):1-8. PubMed ID: 11058695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha (TNFalpha) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL).
    Cavallo MG; Montali A; Monetini L; Valente L; Mariani P; Bifolco M; Sirinian MI; Antonini TM; Fioretti F; Campagna F; Verna R; Arca M
    Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):262-9. PubMed ID: 16054550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
    Modzelewski B
    Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
    Warzocha K; Bienvenu J; Ribeiro P; Moullet I; Dumontet C; Neidhardt-Berard EM; Coiffier B; Salles G
    Br J Cancer; 1998 Jun; 77(12):2357-62. PubMed ID: 9649158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
    Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
    J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma tumor necrosis factor-alpha, its soluble receptors and interleukin-1beta levels in critically burned patients.
    Zhang B; Huang YH; Chen Y; Yang Y; Hao ZL; Xie SL
    Burns; 1998 Nov; 24(7):599-603. PubMed ID: 9882056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
    Haack M; Reichenberg A; Kraus T; Schuld A; Yirmiya R; Pollmächer T
    Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange.
    van Deuren M; Frieling JT; van der Ven-Jongekrijg J; Neeleman C; Russel FG; van Lier HJ; Bartelink AK; van der Meer JW
    Clin Infect Dis; 1998 Apr; 26(4):918-23. PubMed ID: 9564476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
    Tur-Kaspa I; Maor Y; Weissenberg R; Madgar I; Aderka D; Dor J; Mashiach S; Wallach D
    J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
    Haack M; Pollmächer T; Mullington JM
    Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.
    Kallinowski B; Haseroth K; Marinos G; Hanck C; Stremmel W; Theilmann L; Singer MV; Rossol S
    Clin Exp Immunol; 1998 Feb; 111(2):269-77. PubMed ID: 9486392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity.
    Bigda J; Beletsky I; Brakebusch C; Varfolomeev Y; Engelmann H; Bigda J; Holtmann H; Wallach D
    J Exp Med; 1994 Aug; 180(2):445-60. PubMed ID: 7519237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
    Joyce DA; Steer JH
    J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans--a possible explanation for the circadian kinetics of TNR-alpha effects.
    Liebmann PM; Reibnegger G; Lehofer M; Moser M; Pürstner P; Mangge H; Schauenstein K
    Int Immunol; 1998 Sep; 10(9):1393-6. PubMed ID: 9786439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
    Fabris C; Del Forno M; Falleti E; Toniutto P; Pirisi M
    Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.